Olivier Leupin

Novartis (Switzerland) — Switzerland

Engineering · Physical Sciences

15h-index1.6kcitations31works3.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

3D Printing in Biomedical Research(10), Hepatitis B Virus Studies(4), Tendon Structure and Treatment(4), HIV Research and Treatment(3), Bone Metabolism and Diseases(3)

Publications31 total

Targeting the IL-17A pathway for therapy in early-stage tendinopathy
RMD Open·2025· 3 citedOpen Access
A Novel Microplate 3D Bioprinting Platform for the Engineering of Muscle and Tendon Tissues
SLAS TECHNOLOGY·2018· 101 citedOpen Access
Minimal mechanical load and tissue culture conditions preserve native cell phenotype and morphology in tendon—a novel ex vivo mouse explant model
Journal of Orthopaedic Research®·2017· 42 citedOpen Access
3D bioprinted tissue models for substance testing
Zürcher Hochschule für Angewandte Wissenschaften digital collection (Zurich University of Applied Sciences)·2017
Bioprinted tissues for substance testing
Zürcher Hochschule für Angewandte Wissenschaften digital collection (Zurich University of Applied Sciences)·2016
3D tissue models : new perspectives in medicine
Zürcher Hochschule für Angewandte Wissenschaften digital collection (Zurich University of Applied Sciences)·2016
A novel multiwell device for drug development with bioprinted 3D human tendon and skeletal muscle tissues
Zürcher Hochschule für Angewandte Wissenschaften digital collection (Zurich University of Applied Sciences)·2016
Bioprinted tissue models for substance evalution
Zürcher Hochschule für Angewandte Wissenschaften digital collection (Zurich University of Applied Sciences)·2016
Bioprinted tissues for substance evaluation
Zürcher Hochschule für Angewandte Wissenschaften digital collection (Zurich University of Applied Sciences)·2016
A novel multiwell device for drug development with bioprinted 3D human tendon and skeletal muscle tissues
Zürcher Hochschule für Angewandte Wissenschaften digital collection (Zurich University of Applied Sciences)·2015
3D Bioprinted Muscle and Tendon Tissues for Drug Development
CHIMIA International Journal for Chemistry·2015· 15 citedOpen Access
Bioprinted soft tissue models for compound testing
Zürcher Hochschule für Angewandte Wissenschaften digital collection (Zurich University of Applied Sciences)·2015
Soft tissue bioprinting in tissue engineering for drug development
Zürcher Hochschule für Angewandte Wissenschaften digital collection (Zurich University of Applied Sciences)·2015
Bioprinted muscle/tendon for drug assessment
Zürcher Hochschule für Angewandte Wissenschaften digital collection (Zurich University of Applied Sciences)·2015
Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels
Proceedings of the National Academy of Sciences·2014· 119 citedOpen Access
Age-dependent regulation of tendon crimp structure, cell length and gap width with strain
Acta Biomaterialia·2014· 50 citedOpen Access
TGF-β regulates sclerostin expression via the ECR5 enhancer
Bone·2011· 57 citedOpen Access
Bone Overgrowth-associated Mutations in the LRP4 Gene Impair Sclerostin Facilitator Function
Journal of Biological Chemistry·2011· 297 citedOpen Access
Mutations in LRP4 lead to high bone density by impaired sclerostin action
Bone·2010
Identification and characterization of 2 missense mutations in the LRP4 gene causing increased bone mineral density
Bone·2010· 2 cited
page 1 of 2Next →

Frequent Co-authors

Sandra Laternser(12), Ursula Graf‐Hausner(12), Markus Rimann(12), H. J. Keller(10), Epifania Bono(9), Michaela Kneissel(7), Michael Nosswitz(6), Carsten Wagner(6), Michel Strubin(5), Alexandre Morel(5), Ina Krämer(4), H. J. Keller(4), Séverine Bontron(4), Elke Piters(3), Manuel Bueno Sánchez(3), Peter Itin(3), Eveline Boudin(3), Fenna de Freitas(3), Wim Van Hul(3), Céline Schaeffer(3)